Down-regulation of MiR-338-3p and Up-regulation of MACC1 Indicated Poor Prognosis of Epithelial Ovarian Cancer Patients

Overview

Journal J Cancer

Specialty Oncology

Date 2019 Apr 30

PMID 31031848

Citations 15

Authors

Ruitao Zhang

Huirong Shi

Fang Ren

Zheying Liu

Pengcheng Ji

Weiwei Zhang

Wenwen Wang

Affiliations

Soon will be listed here.

Abstract

To detect the expression of microRNA-338-3p (miR-338-3p) and MET transcriptional regulator MACC1 (MACC1) gene in different ovarian tissues, to analyze their relationships, their correlations to the clinicopathologic characteristics of epithelial ovarian cancer and their significant to the progression of ovarian cancer. The expression of miR-338-3p and MACC1 gene in 20 specimens of normal ovarian tissues, 20 specimens of benign epithelial ovarian tumor and 65 specimens of epithelial ovarian cancer was detected by real-time PCR method. Their interrelationships and their correlations to the clinicopathologic characteristics of epithelial ovarian cancer were analyzed. Risk factors of recurrence and death were discussed by binary Logistic regression analysis. The relations between miR-338-3p and MACC1 expression and the survival of ovarian cancer were measured by Kaplan-Meier analysis. The expressions of miR-338-3p and MACC1 gene in epithelial ovarian cancer tissues were (0.331±0.038) and (0.774±0.025), significant differences were noted between epithelial ovarian cancer and normal ovarian tissues, benign ovarian tumors (F=77.916, =1.205E-18; F=77.945, =1.187E-18). In different ovarian tissues, miR-338-3p expression was negatively correlated to MACC1 expression (r = -0.968, <0.0001). In epithelial ovarian cancer, lower expression of miR-338-3p and higher expression of MACC1 were associated with more advanced FIGO stage, higher histological grade and developed lymph node metastasis. Down-regulation of miR-338-3p was related with the recurrence (=0. 005, OR=12.862, 95%CI: 2.120~78.026) and death (=0. 007, OR=12.837, 95%CI: 2.205~81.389) of ovarian cancer patients, which was showed by binary Logistic regression analysis. Compared to other patients, the overall survival rate and progression free survival rate of patients with lower miR-338-3p and higher MACC1 expression were obviously poorer (χ=16.955, =7.219E-5; χ=18.929, =2.828E-5). Down-regulation of miR-338-3p and up-regulation of MACC1 gene were closely related with the poor prognosis of epithelial ovarian cancer patients, which could served as bio-markers of the progression and recurrence of ovarian cancer.

Citing Articles

MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis.

Rezaee A, Ahmadpour S, Jafari A, Aghili S, Tamehri Zadeh S, Rajabi A Front Oncol. 2023; 13:1215194.

PMID: 37854681 PMC: 10580988. DOI: 10.3389/fonc.2023.1215194.

Abnormal expressions of PURPL, miR-363-3p and ADAM10 predicted poor prognosis for patients with ovarian serous cystadenocarcinoma.

Zhang R, Guo X, Zhao L, He T, Feng W, Ren S J Cancer. 2023; 14(15):2908-2918.

PMID: 37781085 PMC: 10539555. DOI: 10.7150/jca.87405.

Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.

Tian W, Yang X, Yang H, Lv M, Sun X, Zhou B Cell Death Dis. 2021; 12(11):1030.

PMID: 34718336 PMC: 8557210. DOI: 10.1038/s41419-021-04314-2.

Disregulations of PURPL and MiR-338-3p Could Serve As Prognosis Biomarkers for Epithelial Ovarian Cancer.

Zhang R, He T, Shi H, Yuan C, Wei F, Liu Z J Cancer. 2021; 12(18):5674-5680.

PMID: 34405027 PMC: 8364645. DOI: 10.7150/jca.61327.

Upregulation of MicroRNA-34a Sensitizes Ovarian Cancer Cells to Resveratrol by Targeting Bcl-2.

Yao S, Gao M, Wang Z, Wang W, Zhan L, Wei B Yonsei Med J. 2021; 62(8):691-701.

PMID: 34296546 PMC: 8298871. DOI: 10.3349/ymj.2021.62.8.691.

References

Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

Zamore P, Haley B . Ribo-gnome: the big world of small RNAs. Science. 2005; 309(5740):1519-24. DOI: 10.1126/science.1111444. View

Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I . MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2008; 15(1):59-67. DOI: 10.1038/nm.1889. View

Shirahata A, Shinmura K, Kitamura Y, Sakuraba K, Yokomizo K, Goto T . MACC1 as a marker for advanced colorectal carcinoma. Anticancer Res. 2010; 30(7):2689-92. View

Shirahata A, Sakata M, Kitamura Y, Sakuraba K, Yokomizo K, Goto T . MACC 1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res. 2010; 30(9):3441-4. View

Shimokawa H, Uramoto H, Onitsuka T, Chundong G, Hanagiri T, Oyama T . Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg. 2010; 141(4):895-8. DOI: 10.1016/j.jtcvs.2010.09.044. View

Shirahata A, Fan W, Sakuraba K, Yokomizo K, Goto T, Mizukami H . MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res. 2011; 31(3):777-80. View

Huang X, Chen J, Wang Q, Chen X, Wen L, Chen L . miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol. 2011; 225(3):463-72. DOI: 10.1002/path.2877. View

Zhang R, Shi H, Chen Z, Wu Q, Ren F, Huang H . Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. J Exp Clin Cancer Res. 2011; 30:83. PMC: 3182136. DOI: 10.1186/1756-9966-30-83. View

10.

Zhang R, Shi H, Huang H, Chen Z, Liu H, Yuan Z . [Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance]. Nan Fang Yi Ke Da Xue Xue Bao. 2011; 31(9):1551-5. View

11.

Iorio M, Croce C . microRNA involvement in human cancer. Carcinogenesis. 2012; 33(6):1126-33. PMC: 3514864. DOI: 10.1093/carcin/bgs140. View

12.

Shen G, Li X, Jia Y, Piazza G, Xi Y . Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin. 2013; 34(3):336-41. PMC: 3587916. DOI: 10.1038/aps.2012.195. View

13.

Wang L, Wu Y, Lin L, Liu P, Huang H, Liao W . Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer. 2013; 133(6):1419-30. DOI: 10.1002/ijc.28140. View

14.

Sun K, Deng H, Lei S, Dong J, Li G . miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened. World J Gastroenterol. 2013; 19(14):2197-207. PMC: 3627884. DOI: 10.3748/wjg.v19.i14.2197. View

15.

Chen X, Pan M, Han L, Lu H, Hao X, Dong Q . miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a. FEBS Lett. 2013; 587(22):3729-37. DOI: 10.1016/j.febslet.2013.09.044. View

16.

Xue Q, Sun K, Deng H, Lei S, Dong J, Li G . MicroRNA-338-3p inhibits colorectal carcinoma cell invasion and migration by targeting smoothened. Jpn J Clin Oncol. 2013; 44(1):13-21. DOI: 10.1093/jjco/hyt181. View

17.

Wang Y, Hong Q, Wang J, Fang Y, Hu C . Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion. Tumour Biol. 2014; 35(4):3771-8. DOI: 10.1007/s13277-013-1499-z. View

18.

Zhang R, Ren F, Shi H . [Expression of metastasis-associated in colon cancer-1 in different stages of epithelial ovarian cancer]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014; 36(1):47-51. DOI: 10.3881/j.issn.1000-503X.2014.01.009. View

19.

Sun K, Su G, Deng H, Dong J, Lei S, Li G . Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma. Chin Med J (Engl). 2014; 127(10):1884-90. View

20.

Sheng X, Li Z, Sun M, Wang Z, Zhou D, Li J . MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET. Oncol Lett. 2014; 8(2):891-897. PMC: 4081430. DOI: 10.3892/ol.2014.2184. View